1. Home
  2. RGS vs PRLD Comparison

RGS vs PRLD Comparison

Compare RGS & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$27.39

Market Cap

71.3M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$2.45

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
PRLD
Founded
1922
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
69.1M
IPO Year
1991
2020

Fundamental Metrics

Financial Performance
Metric
RGS
PRLD
Price
$27.39
$2.45
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
5.3K
429.6K
Earning Date
02-11-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
20.05
N/A
EPS
45.08
N/A
Revenue
$223,032,000.00
$10,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.65
N/A
Revenue Growth
13.98
250.00
52 Week Low
$15.00
$0.61
52 Week High
$31.50
$4.22

Technical Indicators

Market Signals
Indicator
RGS
PRLD
Relative Strength Index (RSI) 41.51 68.38
Support Level $28.04 $1.90
Resistance Level $30.17 $2.38
Average True Range (ATR) 0.83 0.19
MACD -0.10 0.07
Stochastic Oscillator 0.00 96.12

Price Performance

Historical Comparison
RGS
PRLD

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: